...
首页> 外文期刊>Molecular cytogenetics >A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report
【24h】

A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report

机译:罕见的t(11; 22)病例在套细胞淋巴瘤(如B细胞瘤形成)中导致IGL和CCND1融合:病例报告

获取原文

摘要

The chromosomal translocation (11;14)(q13;q32) rearranging the locus for cyclin D1 (CCND1) to that of the immunoglobulin heavy chain (IGH) can be found in virtually all cases of mantle cell lymphoma (MCL), while other CCND1 translocations are extremely rare. As CCND1 overexpression and activation is a hallmark of MCL it is regarded as a central biological mechanism in the development and maintenance of this disease. Here we present a patient initially diagnosed with chronic lymphocytic leukemia (CLL) where chromosome banding analysis revealed, among other aberrations, a translocation (11;22)(q13;q11.2). We show by fluorescence in situ hybridization (FISH) analysis that on chromosome 22 the immunoglobulin light chain lambda (IGL) is involved in this cytogenetic aberration. Additionally, we demonstrate the resulting overexpression of CCND1 on the RNA and protein level, thereby consolidating the new diagnosis of a MCL-like B-cell neoplasia. Summing up, we described a rare case of t(11;22)(q13;q11.2) in a MCL-like neoplasia and showed that this aberration leads to an overexpression of CCND1 which is regarded as a key biological feature in MCL. This case underlines the importance of cytogenetic analyses especially in atypical cases of B cell lymphomas.
机译:几乎在所有套细胞淋巴瘤(MCL)病例中均可发现染色体易位(11; 14)(q13; q32)将细胞周期蛋白D1(CCND1)重排至免疫球蛋白重链(IGH)的位置。易位极为罕见。由于CCND1的过表达和激活是MCL的标志,因此被认为是该疾病发生和维持的主要生物学机制。在这里,我们介绍了一名最初被诊断为慢性淋巴细胞性白血病(CLL)的患者,该患者的染色体谱带分析显示,在其他畸变中,易位(11; 22)(q13; q11.2)。我们通过荧光原位杂交(FISH)分析表明,在22号染色体上,免疫球蛋白轻链λ(IGL)参与了这种细胞遗传畸变。此外,我们证明了CCND1在RNA和蛋白质水平上的过表达,从而巩固了MCL样B细胞瘤形成的新诊断。总而言之,我们描述了在MCL样瘤形成中罕见的t(11; 22)(q13; q11.2)病例,并表明这种畸变导致CCND1的过表达,CCND1被认为是MCL中的关键生物学特征。该病例强调了细胞遗传学分析的重要性,尤其是在非典型B细胞淋巴瘤病例中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号